Towards Healthcare
U.S. Compounding Pharmacy Market to Lead USD 12.02 Bn by 2034

U.S. Compounding Pharmacy Market Expands with AI Impact

According to forecasts, the global U.S. compounding pharmacy market will grow from USD 6.57 billion in 2024 to USD 12.02 billion by 2034, with an expected CAGR of 6.24%. The rising incidence of chronic conditions like diabetes, arthritis, and cancer necessitates ongoing treatment regimens. Compounded medications offer flexibility in dosing and formulation, accommodating the complex needs of these patients.

Content

  • Insight Code: 6201
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The U.S. compounding pharmacy market currently in 2025 records USD 6.98 billion and is anticipated to grow to USD 12.02 billion by 2034, advancing at a CAGR of 6.24% from 2024 to 2034.

The South U.S. is leading the U.S. compounding pharmacy market share by 30% due to the increasing demand for personalized medicines, rising investment & funding, and the presence of major key players.

Key trends include the growing need for biologics, advancements in manufacturing technology, and increasing collaborations.

Alliance for Pharmacy Compounding, Personalized Medicine Coalition, PCAB Accreditation for Compounding Pharmacies ACHC, American College of Apothecaries ACA, Food and Drug Administration, clinicaltrials.gov
Any Questions